IDXX

IDEXX Laboratories
D

IDXX

Arincen86/100B

IDEXX Laboratories return on equity (ROE)

IDEXX Laboratories's return on equity is 63.25%: net income of 1.18B USD over the last twelve months on shareholders' equity of 1.87B USD.

Today
63.25%
Average, 5 years
78.97%
Low, 5 years
53.51%
High, 5 years
145.27%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 1.18B ÷ 1.87B = 63.25%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is IDEXX Laboratories's return on equity so high?

Net margin
24.6%
profit on each dollar of sales
Asset turnover
1.28×
sales on each dollar of assets
Equity multiplier
2.09×
assets on each dollar of equity
Return on equity
66.0%
FY2025
  • FY202524.6% × 1.28 × 2.09 = 66.0%
  • FY202422.8% × 1.18 × 2.06 = 55.7%
  • FY202323.1% × 1.12 × 2.20 = 56.9%
  • FY202220.2% × 1.23 × 4.51 = 111.6%
  • FY202123.2% × 1.32 × 3.53 = 107.9%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today63.25%1.18B1.87B
FY202531 Dec 202565.99%1.06B1.61B
FY202431 Dec 202455.65%887.87M1.60B
FY202331 Dec 202356.92%845.04M1.48B
FY202231 Dec 2022111.56%679.09M608.74M
FY202131 Dec 2021107.95%744.84M689.99M
FY202031 Dec 202092.10%582.13M632.09M
FY201931 Dec 2019241.05%427.79M177.47M
FY201831 Dec 2018—377.05M-9.51M
FY201731 Dec 2017—263.27M-54.11M
FY201631 Dec 2016—222.05M-108.35M
FY201531 Dec 2015—192.14M-84.13M
FY201431 Dec 2014154.83%181.95M117.52M
FY201331 Dec 201336.24%187.79M518.19M
FY201231 Dec 201228.02%178.29M636.22M
FY201131 Dec 201129.98%161.75M539.58M
FY201031 Dec 201024.61%141.32M574.24M
FY200931 Dec 200923.75%122.24M514.57M
FY200831 Dec 200826.51%116.17M438.19M
FY200731 Dec 200721.45%94.01M438.32M
FY200631 Dec 200622.86%93.68M409.86M
FY200531 Dec 200521.21%78.25M369.01M
FY200431 Dec 200419.70%78.33M397.66M
FY200331 Dec 200313.81%57.09M413.29M
FY200231 Dec 200213.31%45.39M340.97M
FY200131 Dec 200112.47%37.62M301.73M
FY200031 Dec 200014.00%36.63M261.75M
FY199931 Dec 199911.47%32.60M284.30M
FY199831 Dec 1998-4.94%-15.20M307.80M
FY199731 Dec 1997-6.97%-21.10M302.70M
FY199631 Dec 199610.10%32.60M322.70M
FY199531 Dec 19957.70%21.50M279.10M
FY199431 Dec 199413.33%13.30M99.80M
FY199331 Dec 199311.60%9.70M83.60M
FY199231 Dec 19926.96%4.90M70.40M
FY199131 Dec 199110.16%3.20M31.50M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Debt to equity,Current ratio,All ratios

Common questions about IDEXX Laboratories's ROE

Source: Financial Modeling Prep